Continuing bevacizumab with second-line chemotherapy for metastatic colorectal cancer prolongs survival

被引：0
|
作者：
不详
机构：
来源：
COLORECTAL CANCER | 2012年 / 1卷 / 04期
关键词：
D O I：
10.2217/CRC.12.43
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：281 / 282
页数：2
相关论文
共 50 条
  • [31] IROX as second-line therapy for metastatic colorectal cancer
    Alberto Sobrero
    [J]. Nature Reviews Clinical Oncology, 2009, 6 : 248 - 250
  • [32] Options for Second-Line Treatment in Metastatic Colorectal Cancer
    Lee, James J.
    Sun, Weijing
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (01) : 46 - 54
  • [33] Second-line systemic therapy for metastatic colorectal cancer
    Mocellin, Simone
    Baretta, Zora
    Roque i Figuls, Marta
    Sola, Ivan
    Martin-Richard, Marta
    Hallum, Sara
    Cosp, Xavier Bonfill
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (01):
  • [34] Second-line treatment of patients with metastatic colorectal cancer
    Rougier, P
    Lepere, C
    [J]. SEMINARS IN ONCOLOGY, 2005, 32 (06) : S48 - S54
  • [35] Irinotecan in second-line therapy of metastatic colorectal cancer
    Jäger, E
    Jäger, D
    Orth, J
    Knuth, A
    [J]. ONKOLOGIE, 2000, 23 : S15 - S17
  • [36] IROX as second-line therapy for metastatic colorectal cancer
    Sobrero, Alberto
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (05) : 248 - 250
  • [37] Clinical benefits of stabilization after second-line chemotherapy in patients with metastatic colorectal cancer
    Henry-Launois, B
    Becouarn, Y
    Aussage, P
    [J]. BULLETIN DU CANCER, 1999, 86 (02) : 195 - 201
  • [38] Irinotecan plus raltitrexed as second-line chemotherapy for metastatic colorectal cancer: A retrospective study
    Lian, Jie
    Wang, Ren
    Wang, Xin
    Pang, Xiangyi
    Xu, Benjie
    Tang, Shuli
    Shao, Jiayue
    Lu, Haibo
    [J]. ONCOLOGY LETTERS, 2024, 28 (03)
  • [39] Target hepatic artery regional chemotherapy and bevacizumab perfusion in liver metastatic colorectal cancer after failure of first-line or second-line systemic chemotherapy
    Chen, Hui
    Zhang, Ji
    Cao, Guang
    Liu, Peng
    Xu, Haifeng
    Wang, Xiaodong
    Zhu, Xu
    Gao, Song
    Guo, Jianhai
    Zhu, Linzhong
    Zhang, Pengjun
    [J]. ANTI-CANCER DRUGS, 2016, 27 (02) : 118 - 126
  • [40] Efficacy of second-line chemotherapy after a first-line triplet in patients with metastatic colorectal cancer
    Bazarbashi, S.
    Hakoun, A. M.
    Gad, A. M.
    Elshenawy, M. A.
    Aljubran, A.
    Alzahrani, A. M.
    Eldali, A.
    [J]. CURRENT ONCOLOGY, 2019, 26 (01) : E24 - E29
12345